Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PEG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QPCT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1549L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CELSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP8A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCNN1G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADTRP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AEBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTR2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on